Phentermine HCL C-IV
- Product NDC
- 72189-669
- 11-digit product format
- 721890669
- Labeler code
- 72189
- Product ID
- 72189-669_4cec0e47-5374-2133-e063-6394a90a2009
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Phentermine HCL C-IV
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA040526
- Marketing category
- ANDA
- Marketing start
- 2026-03-13
- Substance
- PHENTERMINE HYDROCHLORIDE
- Active strength
- 37.5 mg/1
- Pharmacologic classes
- Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Phentermine HCL C-IV
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PHENTERMINE HYDROCHLORIDE | 37.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0K2I505OTV |
| Rxcui | 803353 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72189-669-30 | Phentermine HCL C-IV | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72189-669-30 | 72189066930 | 30 TABLET in 1 BOTTLE (72189-669-30) | 30 tablet | 2026-03-13 | No | No | Historical |